Effect of triglyceride oil on prevention of neonatal jaundice

Evaluation of the effect of oral Medium-Chain Triglycerides oil in healthy Late preterm infants in the prevention of icter

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20081021001378N12

Enrollment

Registered

2020-10-04

Start date

2019-08-23

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperbillirubinemia in term neonates ?.

Interventions

Intervention 1: Intervention group: Infants fed one cc of MCT oil per kg body weight plus breast milk on the first day of birth. Intervention 2: Control group: Normal feeding is only with breast milk.

Eligibility

Sex/Gender

All

Age

1 Days to 30 Days

Inclusion criteria

Inclusion criteria: Preterm infant 34-36 weeks gestation age

Exclusion criteria

Exclusion criteria: ABO or Rh incompatibility Cephalhematoma Low apgar Subglacial bleeding Congenital anomaly Infection

Design outcomes

Primary

Measure	Time frame
Transcutanous bilirubin levels. Timepoint: During the first 5 days after birth. Method of measurement: Using Transcutaneous bilirubin meter - JH20-1A by NINGBO DAVIS MEDICAL Company.;Daily weight information. Timepoint: Before the intervention, on the first day and 2 days after commencement of the study. Method of measurement: Clinical observation.;Number of defecation. Timepoint: Before the intervention, on the first day and 2 days after commencement of the study. Method of measurement: Clinical observation.	—

Measure

Time frame

Transcutanous bilirubin levels. Timepoint: During the first 5 days after birth. Method of measurement: Using Transcutaneous bilirubin meter - JH20-1A by NINGBO DAVIS MEDICAL Company.;Daily weight information. Timepoint: Before the intervention, on the first day and 2 days after commencement of the study. Method of measurement: Clinical observation.;Number of defecation. Timepoint: Before the intervention, on the first day and 2 days after commencement of the study. Method of measurement: Clinical observation.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeed Esmaeili

Mashhad University of Medical Sciences

nrc@mums.ac.ir+98 51 3852 1121

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026